✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

GSK plc

Common Name
GSK
Country
United Kingdom
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
68,629
Ticker
GSK
Exchange
LONDON STOCK EXCHANGE
Description
GSK plc is a leading global healthcare company that researches, develops, and manufactures innovative pharmaceutical and consumer healthcare products. This company primarily focuses on creating vaccin...

GSK's Financial Statements Preview

Below are the financial statements of GSK, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of GBP
2024
2023
2022
Turnover
31,376a
30,328a
29,324a
Cost of sales
-9,048a
-8,565a
-9,554a
Gross profit
22,328a
21,763a
19,770a
Selling, general and administration
-11,015a
-9,385a
-8,372a
Research and development
-6,401a
-6,223a
-5,488a
Royalty income
639a
953a
758a
Other operating income/(expense)
-1,530a
-363a
-235a
Operating profit
4,021a
6,745a
6,433a
Finance income
122a
115a
76a
Finance expense
-669a
-792a
-879a
Share of after tax profit/(loss) of associates and joint ventures
-3a
-5a
-2a
Profit/(loss) on disposal of interests in associates and joint ventures
6a
1a
0a
Profit before taxation
3,477a
6,064a
5,628a
Taxation
-526a
-756a
-707a
Profit after taxation from continuing operations
2,951a
5,308a
4,921a
Profit after taxation from discontinued operations and other gains/(losses) from the demerger
0a
0a
3,049a
Re-measurement of discontinued operations distributed to shareholders on demerger
0a
0a
7,651a
Profit after taxation from discontinued operations
0a
0a
10,700a
Total profit after taxation for the year
2,951a
5,308a
15,621a
Profit attributable to non-controlling interests from continuing operations
376a
380a
460a
Profit attributable to shareholders from continuing operations
2,575a
4,928a
4,461a
Profit attributable to non-controlling interests from discontinued operations
0a
0a
205a
Profit attributable to shareholders from discontinued operations
0a
0a
10,495a
Total profit attributable to non-controlling interests
376a
380a
665a
Total profit attributable to shareholders
2,575a
4,928a
14,956a
Limited Data Preview
You are viewing a limited preview of GSK’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind GSK’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore GSK’s data sources below and access millions more through our Disclosure Search.

a. GSK's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?